• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Odyssey Health Inc (OP:ODYY)

0.0329 UNCHANGED
Streaming Delayed Price Updated: 3:57 PM EST, Dec 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 95
Open 0.0329
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0329
Today's Range 0.0329 - 0.0329
52wk Range 0.0050 - 0.1250
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Odyssey Health Closes Asset Sale of its Neurological Drug Technology Pipeline Including Concussion Drug Candidate with Oragenics, Inc.
January 02, 2024
Via ACCESSWIRE
News headline image
Odyssey Health, Inc. Gains Shareholder Approval for Asset Sale with Oragenics, Inc.
December 12, 2023
Via ACCESSWIRE

Performance

YTD
N/A
N/A
1 Month
-25.2%
-25.2%
3 Month
-58.9%
-58.9%
6 Month
-5.2%
-5.2%
1 Year
+36.5%
+36.5%

More News

Read More
News headline image
Odyssey Health, Inc, Selects Syneos Health to Support Investigational New Drug Application for Treatment of Concussion
November 16, 2023
Via ACCESSWIRE
News headline image
Odyssey Health, Inc. to Provide Company Update and Webcast for Shareholders
November 15, 2023
Via ACCESSWIRE
News headline image
Odyssey Health, Inc. Provides Update on Asset Purchase Agreement with Oragenics, Inc.
October 18, 2023
Via ACCESSWIRE
News headline image
Oragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug Candidate
October 05, 2023
From Oragenics, Inc.
Via Business Wire
News headline image
Odyssey Health Inc. Begins Trading on the OTCQB
October 04, 2023
Via ACCESSWIRE
News headline image
Odyssey Health, Inc. Presents Concussion Treatment Data at the Military Health System Research Symposium - MHSRS
August 23, 2023
Via ACCESSWIRE
News headline image
Odyssey Health, Inc. Presents Data at the Special Operations Medical Association - Scientific Assembly
June 08, 2023
Via ACCESSWIRE
Odyssey Health, Inc. Preparing for a Phase II Pharmaceutical Concussion Treatment
March 30, 2023
Via TheNewswire.com
News headline image
Odyssey Health, Inc. Preparing for a Phase II Pharmaceutical Concussion Treatment
March 30, 2023
Via News Direct
News headline image
Odyssey Health, Inc. Forms Community-Based Partnership with David R. Metcalf Foundation for Military Concussion Research
February 07, 2023
Via News Direct
Topics Death
Odyssey Health, Inc. (ODYY) To Give Corporate Update at Scheduled Annual Meeting of Stockholders in January 2023
December 01, 2022
Via Investor Brand Network
Topics Animal Testing
BioMedNewsBreaks – Odyssey Health Inc. (ODYY) Reports on Concussion Drug Progress, Provides Corporate Update
November 23, 2022
Via Investor Brand Network
Topics Intellectual Property
World Cup 2022 to Feature New Protocol to Respond to Suspected Concussions
November 22, 2022
Via Investor Brand Network
Odyssey Health, Inc. (ODYY) Expands Executive Team of New Subsidiary in Strategic Move to Strengthen Marketing of Concussion, Neurological Therapies
November 21, 2022
Via Investor Brand Network
Surgical Team in Spain Completes First-Ever Intestinal Transplant
November 17, 2022
Via Investor Brand Network
BioMedNewsBreaks – Odyssey Health Inc. (ODYY) Announces Upcoming Annual Meeting of Stockholders
November 15, 2022
Via Investor Brand Network
Topics Intellectual Property
Odyssey Health, Inc. (ODYY) Focuses on Medical Devices Market with US Patent Application on Breath-Propelled Intranasal Delivery Device
November 14, 2022
Via Investor Brand Network
Topics Intellectual Property
Study Finds Iron Causes Chronic Heart Failure in Heart Attack Survivors
November 09, 2022
Via Investor Brand Network
New Pharmaceutical Subsidiary Geared to Aid Odyssey Health, Inc. (ODYY) Development of Novel Solutions for Brain Related Medical Treatments
November 07, 2022
Via Investor Brand Network
Experts Concerned That Concussion Protocols Don’t Factor in Women
November 04, 2022
Via Investor Brand Network
BioMedNewsBreaks – Odyssey Health Inc. (ODYY) Announces Expansion of Executive Team
November 03, 2022
Via Investor Brand Network
Topics Intellectual Property
BioMedNewsBreaks – Odyssey Health Inc. (ODYY) Files for Patent Protection on Novel Breath-Propelled Intranasal Brain-Drug Delivery Device
November 01, 2022
Via Investor Brand Network
Topics Intellectual Property
BioMedNewsBreaks – Odyssey Health Inc. (ODYY) Pleased with Safety Profile of Its PRV-002 Concussion Treatment
October 31, 2022
Via Investor Brand Network
Topics Intellectual Property

Frequently Asked Questions

Is Odyssey Health Inc publicly traded?
Yes, Odyssey Health Inc is publicly traded.
What exchange does Odyssey Health Inc trade on?
Odyssey Health Inc trades on the OTC Traded
What is the ticker symbol for Odyssey Health Inc?
The ticker symbol for Odyssey Health Inc is ODYY on the OTC Traded
What is the current price of Odyssey Health Inc?
The current price of Odyssey Health Inc is 0.0329
When was Odyssey Health Inc last traded?
The last trade of Odyssey Health Inc was at 12/31/25 03:57 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap